Last $3.08 USD
Change Today +0.164 / 5.62%
Volume 242.7K
ADXS On Other Exchanges
Symbol
Exchange
NASDAQ CM
Stuttgart
As of 8:10 PM 11/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark J. Rosenblum CPA

Former Chief Financial Officer, Principal Accounting Officer, Senior Vice President and Secretary, Advaxis, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 3 different industries.

61$576,119
As of Fiscal Year 2013

Background*

Mr. Mark J. Rosenblum, CPA has been the Chief Financial Officer, Principal Accounting Officer, Senior Vice President and Secretary of Advaxis, Inc. since January 5, 2010. Mr. Rosenblum served as the Chief Financial Officer of Hemobiotech Inc. from April 1, 2005 to December 31, 2009 and served as its Secretary. He served as the Chief Accounting Officer of Wellman Inc. from 1996 to 2003 and also served as its Vice President and Controller of Wellman from 1990 to 1996. ...

Read Full Background

Corporate Headquarters*

305 College Road East
Princeton, New Jersey 08540

United States

Phone: 609-452-9813
Fax: 609-452-9818

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of South Carolina
Master's Degree
University of South Carolina

Other Affiliations*

Annual Compensation*

Salary$253,173
Bonus$108,281
Total Annual Compensation$361,454

Stock Options*

Restricted Stock Awards$12,031
All Other Compensation$22,634
Exercisable Options35,200
Unexercisable Options18,400
Total Number of Options53,600

Total Compensation*

Total Annual Cash Compensation$384,088
Total Short Term Compensation$361,454
Other Long Term Compensation$34,665
Total Calculated Compensation$576,119
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADXS:US $3.08 USD +0.164

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Jeffrey D. Abbey MBA, J.D.Chief Executive Officer, President and Director
Argos Therapeutics, Inc.
$436.8K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Hans Arwidsson Ph.D.Chief Executive Officer and President
Eurocine Vaccines AB
--
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADVAXIS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.